Skip to main content
SpringerLink
Log in

Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Flow cytometry (FC), estrogen receptor (ER), and progesterone receptor (PR) analyses were performed on 226 breast cancers. The presence of steroid receptors was inversely proportional to proliferative index and percent aneuploidy. Within the two ER (+ and −) groups, the presence of PR did not add significantly to the comparison. The mean proliferative index for the diploid tumors was 17.5±6.8 compared to 27.8±9.8 for aneuploid tumors (p<.001). The degree of aneuploidy, or DNA index, was not related to cell cycle kinetics or steroid receptor status. In 163 tissues analyzed for percent tumor present, a correlation between the relative number of aneuploid cells and percent tumor in the histologic review was observed. A study of the diploid tumors indicated greater than 75% had at least 10% tumor cells by histologic review. Since with FC one can observe at least 10% aneuploid cells in a tumor sample, it is our opinion that the percent aneuploidy in this study is not artifactually low due to sampling error. There was no significant relationship between nodal status or number of positive nodes and proliferative index, aneuploidy, or steroid receptor status. Metastatic tumors had a higher mean proliferative index, but this was not statistically significant. There was a relationship between age and proliferative index but not between age and ploidy status. In a small group of patients there was a trend for proliferative index and percent aneuploidy to be higher in the poorly differentiated and larger tumors when compared to the well differentiated and smaller tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

FC:

flow cytometry

ER:

estrogen receptor

PR:

progesterone receptor

PI:

proliferative index

References

  1. Allegra JC, Lippman ME, Simon R, Thompson EB, Barlock A, Green L, Huff KK, Do HM, Aitken S, Warren R: Association between steroid hormone receptor status and disease free interval in breast cancer. Cancer Treat Rep 63: 1271–1277, 1979

    PubMed  Google Scholar 

  2. Meyer JS, Lee TY: Relationships of S-phase fraction of breast carcinoma in relapse to duration of remissions, estrogen receptor content, therapeutic responsiveness, and duration of survival. Cancer Res 40: 1890–1896, 1980

    PubMed  Google Scholar 

  3. Coulson PB, Thornthwaite JT, Woolley TW, Sugarbaker EV, Seckinger D: Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Cancer Res 44: 4187–4196, 1984

    PubMed  Google Scholar 

  4. Hedley DW, Rugg CA, Alun BP, Taylor IW: Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res 44: 5395–5398, 1984

    PubMed  Google Scholar 

  5. Ewers SB, Langstrom E, Baldetop B, Killander D: Flow cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry 5: 408–419, 1984

    Article  PubMed  Google Scholar 

  6. Kute TE, Muss HB, Anderson D, Crumb K, Miller B, Burns D, Dube LA: Relationship of steroid receptor, cell kinetics and clinical status in patients with breast cancer. Cancer Res 41: 3524–3529, 1981

    PubMed  Google Scholar 

  7. Kute TE, Huske MS, Shore A, Rhyne AL: Improvements in steroid receptor assays including rapid computer analysis of data. Anal Biochem 103: 272–279, 1980

    Article  PubMed  Google Scholar 

  8. Thornthwaite JT, Sugarbaker EV, Temple WJ: Preparation of tissue for DNA flow cytometric analysis. Cytometry 1: 229–237, 1980

    Article  PubMed  Google Scholar 

  9. Fried J: Method for the quantitative evaluation of data from flow microfluorometry. Comput Biomed Res 9: 263–276, 1976

    Article  PubMed  Google Scholar 

  10. Fisher ER, Gregorio RM, Fisher B: Pathology of invasive breast cancer. Cancer 36: 1–84, 1975

    PubMed  Google Scholar 

  11. Meyer JS, McDivitt RW, Stone KR, Prey MV, Bauer WC: Practical breast carcinoma cell kinetics: review and update. Breast Cancer Res Treat 4: 79–88, 1984

    Article  PubMed  Google Scholar 

  12. McGuire WL, Meyer JS, Barlogie B, Kute TE: Impact of flow cytometry on predicting recurrence and survival in breast cancer patients. Breast Cancer Res Treat 5: 117–128, 1985

    Article  PubMed  Google Scholar 

  13. Meyer JS, Micko S, Craver JL, McDivitt RW: DNA flow cytometry of breast carcinomas after acetic-acid fixation. Cell Tissue Kinet 17: 185–197, 1984

    PubMed  Google Scholar 

  14. Silvestrini R, Daidone MG, DiFronzo G: Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer 44: 665–770, 1979

    PubMed  Google Scholar 

  15. Olszewski W, Darzynkiewicz Z, Rosen PP, Schwarz MK, Melamed HR: Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor. Cancer 48: 985–988, 1981

    PubMed  Google Scholar 

  16. Raber MN, Barlogie B, Latreille J, Bedrossian C, Fritsche H, Blumenschein G: Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Cytometry 3: 36–41, 1982

    Article  PubMed  Google Scholar 

  17. Busch H, Busch RK, Chan PK, Isenberg W, Weigand R, Russo J, Furmanski P: Results of a preliminary ‘blind’ study of the presence of the human tumor nucleolar antigen in breast carcinomas, benign breast tumors and normal breast tissue. Clin Immunol Immunopathol 18: 155–167, 1981

    Article  PubMed  Google Scholar 

  18. Fried J, Perez AG, Clarkson BD: Flow cytometric analysis of cell cycle distribution using propidium iodide. J Cell Biol 71: 172–181, 1976

    Article  PubMed  Google Scholar 

  19. Henderson IC, Canellos GP: Cancer of the breast: the past decade. N Engl J Med 302: 17–30, 1980

    PubMed  Google Scholar 

  20. Gentili C, Sanfilippo O, Silvestrini R: Cell proliferation and its relationship to clinical features and relapse in breast cancer. Cancer 48: 974–979, 1981

    PubMed  Google Scholar 

  21. Tubiana M, Pejovic MF, Renaud A, Contesso G, Chavaudra N, Gioanni J, Maloise EP: Kinetic parameters and the course of the disease in breast. Cancer 47: 937–943, 1981

    PubMed  Google Scholar 

  22. Deshpande N, Mitchell I, Allen D, Morris R: Deoxyribonucleic acid (DNA) content of carcinomas and prognosis in human breast cancer. Int J Cancer 32: 693–696, 1983

    PubMed  Google Scholar 

  23. Taylor IW, Musgrove EA, Friedlander ML, Foo MS, Hedley DW: The influence of age on the DNA ploidy levels of breast tumors. Eur J Cancer Clin Oncol 19: 623–628, 1983

    Article  PubMed  Google Scholar 

  24. Moran RE, Block MM, Alpert L, Straus MJ: Correlation of cell cycle kinetics, hormone receptors, histopathology and nodal status in human breast cancer. Cancer 54: 1586–1590, 1984

    PubMed  Google Scholar 

  25. Bedrossian CMW, Raber M, Barlogie B: Flow cytometry and cytomorphology in primary resectable breast cancer. Anal Quant Cytology 3: 112–116, 1981

    Google Scholar 

  26. Olszewski W, Darzynkiewicz Z, Rosen PP, Schwartz MK, Melamed MR: Flow cytometry of breast cancer: I. Relation of DNA ploidy level to histology and estrogen receptor. Cancer 48: 980–984, 1981

    PubMed  Google Scholar 

  27. Delides GS, Garas G, Georgouli G, Jiortziotis D, Lecca J, Leva T, Elemenoglou J: Intralaboratory variations in the grading of breast carcinoma. Arch Pathol Lab Med 106: 126–128, 1982

    PubMed  Google Scholar 

  28. Sutherland RL, Reddel RR, Green MD: Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens. Eur J Cancer Clin Oncol 19: 307–318, 1983

    Article  PubMed  Google Scholar 

  29. Kute TE, Mehta RG, Linville C: Studies on cell kinetics in normal and neoplastic mammary tissues by flow cytometry. Cytometry 6: 362–367, 1985

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Bowman Gray School of Medicine, 300 S. Hawthorne Road, 27103, Winston-Salem, NC, USA

    Timothy E. Kute Ph.D., Hyman B. Muss, Marbry Hopkins, Richard Marshall, Douglas Case & Leslie Kammire

  2. Department of Pathology, Bowman Gray School of Medicine of Wake Forest University, 27103, Winston-Salem, NC

    Timothy E. Kute Ph.D., Hyman B. Muss, Marbry Hopkins, Richard Marshall, Douglas Case & Leslie Kammire

Authors
  1. Timothy E. Kute Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hyman B. Muss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marbry Hopkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Richard Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Douglas Case
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Leslie Kammire
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kute, T.E., Muss, H.B., Hopkins, M. et al. Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer. Breast Cancer Res Tr 6, 113–121 (1985). https://doi.org/10.1007/BF02235742

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02235742

Key words

Search

Navigation